Pompidou Group presentation
Upcoming SlideShare
Loading in...5
×
 

Like this? Share it with your network

Share

Pompidou Group presentation

on

  • 370 views

 

Statistics

Views

Total Views
370
Views on SlideShare
370
Embed Views
0

Actions

Likes
0
Downloads
1
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment
  • 1 - Link with French Connection (Pompidou wanted to fight the trafficking of heroin between France and the US) 2 - Partial Agreement: "a form of co-operation allowing to pursue certain activities not supported by all member states of the Council of Europe. Consequently, only interested member states participate in such an Agreement and bear the costs. (…)" 3 - annual budget : 1.700.000 € List of member states: Austria, Azerbaijan, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, San Marino, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom. The European Commission is also a member of the PG / Ad hoc participation to the activities of Canada, USA, Holy See Not members yet : Albania, Andorra, Armenia, Bosnia & Herzegovina, Georgia, Latvia, Moldova, Monaco, Montenegro, Serbia, FYROM, Ukraine But technical co-operation with Albania, Latvia, Ukraine
  • WHAT IS OUR ROLE? Triangle Policy makers - Researchers/Scientists – Professionals (practitioners, social workers, etc.)
  • HOW DO WE WORK? Every 4 years, Ministers in charge of drug issues in the member countries are convened to a Ministerial Conference where they are requested to adopt the work programme (currently Work programme 2006-2010 adopted in Strasbourg 2006) PCs meet twice a year to ensure the implementation of the Work Programme Next Ministerial Conference will take place on 3-4 November 2010 in Strasbourg

Pompidou Group presentation Presentation Transcript

  • 1. The Pompidou Group: Its role, structure and activities Patrick Penninckx Executive Secretarypatrick.penninckx@coe.int – www.coe.int/PompidouPower Point Pompidou Group – revised November 2012
  • 2. The European Framework Council of Europe European Union EMCDDADG III – Social Cohesion European CommissionPompidou Group DG - Justice, Freedom andSet up in 1971 securityIncorporated into CoE in 1980 Set up in 1993 • EU Drugs Strategy 2005-2012• Ministerial conference (4 years) Based in Lisbon• Four-Year Work Programme • Action Plan 2005-2008 • Action Plan 2009-2012 Role = provide the EURecent Meetings:15th Ministerial Conference: and its Member States 3-4 November, 2010 with an overview of European drug problems68th Meeting of the PermanentCorrespondents: MoU between30-31 March, 2011 Pompidou Group and EMCDDA, November 2010 2
  • 3. The Pompidou Group(Co-operation Group to Combat Drug Abuse and Illicit Traffickingin Drugs) • is an intergovernmental body formed in 1971 at the suggestion of the French President Georges Pompidou. • Began as an informal co-operation forum of 7 European countries (France, Belgium, Germany, Italy, Luxembourg, Netherlands, United Kingdom) looking to share their experience with combating drug abuse and drug trafficking. • Incorporated into the Council of Europe in 1980. • Co-operation was subsequently extended to include many new countries; at present, the Pompidou Group comprises 35 member states. 3
  • 4. The Role of the Pompidou Group• core mission: contribute to the development of multidisciplinary, innovative, effective and “evidence-based” drug policies in 35 Policy Practice member states.• seeks to link policy, practice and science.• provides a multidisciplinary forum at the wider European level Science where it is possible for policy-makers, professionals and researchers to discuss and exchange information and ideas on the whole range of drug misuse and trafficking problems.• plays a bridging role between EU countries and non-EU countries (Life skills programme in Ukraine) as well as countries from the Mediterranean Region (MedNet.)• cooperates with other Council of Europe initiatives, placing special emphasis on ethical issues and respect of human rights. 4
  • 5. The Pompidou Group’s Structure• Secretariat based in Strasbourg• Ministerial Conference (held every 4 years) -> adopts work programme• Permanent Correspondents = representatives of the 35 member states; senior officials in ministries in charge of drug issues (held biannually)• Currently, the Pompidou Group carries out activities in the following areas: • Prevention • MedNET • Treatment • EXASS Net • Drug Supply Reduction • Cooperation and Assistance Activities • Research • Ethics & Professional Standards 5
  • 6. PreventionAim: Look for innovative and evidence-based practices,define quality standards, and evaluate programs for long-term effectiveness. • Life-skills training (teens building resilience to negative influences) • Prevention of Drug Use in the Workplace • Prevention of Drug Use in Recreational Settings • Consultative Youth Forum on Drugs Prevention • 2004-Polydrug use, 2006-families and youth, (2012- risky youth behaviour) • Drug Prevention Support Network • Conference on drug policy evaluation tools, Prague, May 2010 • The European Drug Prevention Prize (every two years) 6
  • 7. The European Drug Prevention Prize• Created in 2004 to recognise the importance of active youth participation in the development of drug prevention projects• Has since awarded 14 projects with European Drug Prevention Prize• Registered almost 300 applications• Awarded every 2 years -> 2004-2012• 3 drug prevention projects led by youth for youth are rewarded for their work• Monetary benefit: 5000 €, trophy and diploma Prize 2004 Prize 2006 Prize 2008 Prize 2010 Prize 2012 44 applications 31 applications 34 applications 80 applications 83 applications 18 18 15 26 24 countries countries countries countries countries Slovenia Ireland Bulgaria Belgium Germany Switzerland Norway Greece Spain Lebanon United-Kingdom Netherlands United-Kingdom Spain 7
  • 8. The European Drug Prevention Prize • In 2004 and 2006: prize was awarded during the Pompidou Group’s European Drug Prevention Forum • The First Forum took place in Yekaterinburg. 100 participants gathered to discuss the issue of “Poly-drug use: mixing different drugs- new trends in youth culture” • Second Forum was organised in Vilnius and focused on “The involvement of families and young people in drug prevention” In 2010, the jury and the Pompidou Group agreed to open the European Drug Prevention Prize to all 47 Council of Europe member countries In 2012, participation was extended further to the Southern and Eastern rim of the Pompidou Group’s Mediterranean Network (MedNET) …Algeria, Egypt, Jordan, Lebanon and Tunisia 8
  • 9. Treatment Aim: Improve treatment for specific groups by adapting to new trends and assessing the results of different approaches to treatment.• Provided an overview of the treatment systems in 28 countries • Treatment Systems Overview in South-Eastern Europe (March, 2011) • Treatment Systems Overview in Europe (October, 2010)• Adopted a series of recommendations and orientations to improve Clinical Practice practices in the treatment of young (up to 25 years) drug users.• Conferences:– May 2010 Conference on Stimulant Use– May 2009 Guideline development conference focused on bridging the gap between clinical practice and evidence-based practice Evidence-based Practice 9
  • 10. Research Aim: Assessing the impact of research on policy and supporting the use of research evidence in policy and practice.• From 2011-2014, research will now address the following questions: – “what are the best structures to reach coherent drug policies? ” – “what models could be used to test a coherent policy’s effectiveness?” • Ad Hoc expert group on road traffic safety and substitution treatment (2011-2012) • ESSD Summer School- Intensive Course on Qualitative Drug Research for young researchersPrevious Activities include: • Creation of the Register on Drug Research in 2007 • Signaling the latest issues that arise from drug research and promoting interaction between research disciplines (publications) • Developing coherent drug policies • Co-operation with ESPAD and ESSD • Organized MedSPAD surveys in Lebanon, Morocco, Jordan and Egypt. 10
  • 11. Ethical issues and professional standards Aim: Undertake reflections and devise opinions on ethical and professional issues in the following drug and drug abuse-related areas:• Drug Testing – Weighed in on drug screening at school, in the workplace, and on recruitment, the role of insurance companies in the practice of drug testing, – Published the whole report of findings in September 2008, along with a survey of the situation in European schools and legislatures.• “Vaccines" against drugs – Conclusion: As to preventive treatment, it should not be considered under any circumstances, and if “vaccines” were put on the market, very strict application frameworks would have to be set up to avert the risk of misuses.Also:• Organized a round table in 2008 on the theme: “Research and its implications for methods of dealing with drug addiction: the ethical challenges”• Publication on drug addiction in the “Ethical Eye”: “Drug Addiction” (2005) 11
  • 12. Drug Supply ReductionAim: Co-operation among •Objective: developing politicalspecialised services (justice, guidelines that will strengthen Criminal Issues international cooperation, withhealth and care services, socialservices) to find alternative the end goal of a harmonisedmeasures to imprisonment international control strategy Working group on Explore links the elaboration of Between crime and Drug Treatment in guidelines aimed at Drug-use Moldovan Prisons Reducing drug (recidivism) Supply world-wideAirports: (comprises customs and law enforcement officers from 35 countries) Aim: Harmonise tools and systems to improve drug detection in European airports, and enhance subject-related inter-airport cooperation. • Annual reviews of the development of drug seizures at airports • Development of an Airport Crime Risk Register • Promote the undertaking of multilateral drug seizure operational activities • Regular updates of contacts, crime figures, and the Passenger Control Handbook 12
  • 13. Drug Supply ReductionPrecursors:Aim: The prevention of licit and illicit drug precursors’ diversion towards the manufacture of illegal psychoactive substances.Conferences:– 13-14 October, 2011: planned conference on new threats arising in the field of precursor diversion. (Closing the gaps in the judicial chain from the identification of suspect assignments and backtracking to prosecution and sanction).– 30 September - 1 October 2010: Conference on the prevention of drug precursors diversion - perspectives for national and international cooperation.– March 2009: backtracking investigation, evidence collection, sanction and prevention of drug precursors diversion.” The target audience of the conference included magistrates, prosecutors and judges, but also representatives from the chemical industry and law enforcement. 13
  • 14. MedNET • Set up in 2006 • Aim: To improve the quality of drug policy implementation in all participating countries, with greater awareness of the cultural factors influencing intervention policies. • 13 Member countries =Algeria, Cyprus, Egypt, France, Greece, Italy, Jordan, Lebanon, Malta, Morocco, Portugal, Spain, Tunisia• Target groups: : Policy-makers, medical doctors, social workers, NGO representatives, public associations, researchers, and administrative managers. • Geared towards promoting interaction between professionals working on the ground on the political, practical and scientific aspects of drug policy implementation. • Added Value of the Network: MedSPAD- adaptation of European survey methodology and tools to the southern Mediterranean cultural context. 14
  • 15. EXASS NET • Set up in 2007 as a European network between stakeholders at the frontline level. It has since met 6 times, and works at the urban, regional and national levels • Aim: Connecting European professionals and PCs that can provide insights into policy implementation on topics that are of immediate concern to governments. • Addresses topics specific to Permanent Correspondent member cities. Upcoming meetings include: • Berlin, May, 2011- Legal and Illegal Immigrants • October, 2011- How Services Deal with Poly-Drug Use• Member countries: Germany, Croatia, Russian Federation, Finland, Hungary, Moldova, Norway, Netherland, Poland, Portugal, Romania, Slovenia, Ukraine, United-Kingdom• Member cities: Amsterdam, Budapest, Cracow, Frankfurt, Koper, Oslo, Preston, Turku, Viseu, Zagreb, Zaporozhye 15
  • 16. Cooperation ActivitiesCooperation with non-member statesAim: Provide or exchange technical assistance for the development of drug and drugabuse related policies in non-member states, paid for through voluntary contributions.Mediterranean: MedNET•Algeria, Tunisia, Morocco, Lebanon, Egypt, Jordan- • Voluntary contributions from member countries for MedNET programs. •In 2010, this program received 255 000,00 €. •In 2011, it will receive 415 187,00 €. •Capacity building and two-way information exchange through awareness campaigns, national surveys, training seminars, and study visits.Eastern and South Eastern Europe:•Ukraine-Capacity Building, Lifeskills Training•Moldova- Drug Harm Reduction and Treatment in Prisons•Armenia-Reform of the Justice sector through trainings• Romania-Drug Harm Reduction and Treatment in Prisons•Moldova and Transnistria- Rapid Assessment of Drugs Use in Prisons 16
  • 17. Cooperation Activities Aim: Actively seeks cooperation with other European and In-depth study of the possibilities for the co-financing of activities in the International Organisations to European Mediterranean Region between the avoid overlaps and to increase Union European Commission and the Council of synergies. Europe.Namely in the North Africanand Middle East regions. UNODC signed a Memorandum ofParticipation in the Regional EMCDDA Understanding, which will Offices be elaborated in 2011commission on narcotic drugs Pompidou(CND). Group Joined Steering Group on Cooperation on backtracking INCB WHO-HIPP Health in Prisons Programme precursor diversion. to contribute to the drugs in prisons program
  • 18. Cooperation Activities Cooperation activities with the civil society sector:Activities of the Pompidou Group with the following organizations:•ESPAD & MEDSPAD- conduct surveys and collect data on drug use in schools.•ESSD-co-created summer schools, as well as a book on developments in social drug research•European Playwork Association-facilitates the European Drug Prevention Prizes•Mentor Foundation-Collaborates on school-based prevention projects.•Skoun Addictions Centre- “Filling the Gap” project•MENAHRA-cooperation on harm reduction through MedNET•NGO “Innovative Projects in Prisons- cooperation on harm reduction in Moldovan prisons•Syracuse University- collaboration on Trans-Atlantic Executive Training 18
  • 19. For further information, please visit our websitehttp://www.coe.int/t/dg3/pompidou/default_en.asp Or contact our Secretariat directly Pompidou Group Council of Europe F - 67075 Strasbourg - CEDEX pompidou.group@coe.int 19
  • 20. Thank you for your attention! patrick.penninckx@coe.int – www.coe.int/Pompidou 20